We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+1.45%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$77.7B
AUM Growth
+$28.1B
Cap. Flow
+$27.7B
Cap. Flow %
35.64%
Top 10 Hldgs %
8.03%
Holding
3,834
New
1,974
Increased
1,386
Reduced
336
Closed
47

Sector Composition

Rank Sector Weight
1 Technology 15.99%
2 Financials 14.9%
3 Industrials 12.22%
4 Consumer Discretionary 10.07%
5 Healthcare 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALDX icon
2976
Aldeyra Therapeutics
ALDX
$93.5M
$22K ﹤0.01%
+4,257
New +$22.9K
EML icon
2977
Eastern Company
EML
$150M
$22K ﹤0.01%
+887
New +$22.2K
ESCA icon
2978
Escalade
ESCA
$311M
$22K ﹤0.01%
+2,032
New +$22.2K
GWRS icon
2979
Global Water Resources
GWRS
$219M
$22K ﹤0.01%
+1,822
New +$21.5K
ICAD
2980
DELISTED
iCAD Inc
ICAD
$22K ﹤0.01%
+3,219
New +$21K
NWS icon
2981
News Corp Class B
NWS
$17.5B
$22K ﹤0.01%
1,524
-251
-14% -$3.52K
OCUL icon
2982
Ocular Therapeutix
OCUL
$2.02B
$22K ﹤0.01%
+7,115
New +$31.8K
OFS icon
2983
OFS Capital
OFS
$51.9M
$22K ﹤0.01%
+1,876
New +$21.6K
RMTI icon
2984
Rockwell Medical
RMTI
$28.2M
$22K ﹤0.01%
+71
New +$21.8K
ZEUS
2985
DELISTED
Olympic Steel
ZEUS
$22K ﹤0.01%
+1,526
New +$19K
PAMT
2986
PAMT Corp
PAMT
$297M
$22K ﹤0.01%
+1,456
New +$20.1K
ALR
2987
DELISTED
AlerisLife Inc
ALR
$22K ﹤0.01%
+457
New +$2.34K
CFMS
2988
DELISTED
Conformis, Inc. Common Stock
CFMS
$22K ﹤0.01%
+464
New +$27.9K
GSB
2989
DELISTED
GlobalSCAPE, Inc.
GSB
$22K ﹤0.01%
+1,922
New +$22.3K
AVTX icon
2990
Avalo Therapeutics
AVTX
$983M
$21K ﹤0.01%
+2
New +$22.3K
EGY icon
2991
Vaalco Energy
EGY
$594M
$21K ﹤0.01%
+10,120
New +$17.8K
LEE icon
2992
Lee Enterprises
LEE
$182M
$21K ﹤0.01%
+1,039
New +$21.2K
MCHX icon
2993
Marchex
MCHX
$79.7M
$21K ﹤0.01%
+6,559
New +$25.3K
PSNL icon
2994
Personalis
PSNL
$1.51B
$21K ﹤0.01%
+1,443
New +$27.3K
SPRO icon
2995
Spero Therapeutics
SPRO
$73M
$21K ﹤0.01%
+1,988
New +$20.9K
UBX
2996
DELISTED
Unity Biotechnology
UBX
$21K ﹤0.01%
+348
New +$24.6K
ASXC
2997
DELISTED
Asensus Surgical, Inc.
ASXC
$21K ﹤0.01%
+2,559
New +$34.8K
PRTK
2998
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$21K ﹤0.01%
+4,961
New +$19.8K
MBII
2999
DELISTED
Marrone Bio Innovations, Inc.
MBII
$21K ﹤0.01%
+14,555
New +$20.6K
ICBK
3000
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$21K ﹤0.01%
+1,076
New +$19.4K

Similar funds

Victory Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Victory Capital Management held 3,834 positions worth $77.7B, up 57% from $49.6B the previous quarter. Its ten largest holdings account for 8% of the portfolio.

Victory Capital Management deployed $27.7B of net new capital in Q3 2019, opening 1,974 new positions and adding to 1,386 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,479,630 shares worth $316M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Reliance Steel & Aluminium, an estimated $98.7M trimmed.

  • Victory Capital Management's largest Q3 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,479,630 shares worth $316M.
  • Victory Capital Management added most to Microsoft in Q3 2019, an estimated $891M increase.
  • Victory Capital Management's biggest Q3 2019 reduction was Reliance Steel & Aluminium, cutting an estimated $98.7M.
  • Victory Capital Management fully exited Electronics for Imaging in Q3 2019, selling an estimated $61.5M.
  • Victory Capital Management's ten largest holdings make up 8% of its $77.7B portfolio in Q3 2019.
  • Victory Capital Management opened 1,974 new positions and closed 47 in Q3 2019.
  • Victory Capital Management's portfolio value rose 57% quarter-over-quarter to $77.7B.

Based on Victory Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.